IRINOTECAN BAXTER irinotecan hydrochloride trihydrate 40 mg/2 mL concentrated injection vial Austrálie - angličtina - Department of Health (Therapeutic Goods Administration)

irinotecan baxter irinotecan hydrochloride trihydrate 40 mg/2 ml concentrated injection vial

baxter healthcare pty ltd - irinotecan hydrochloride trihydrate, quantity: 40 mg - injection, concentrated - excipient ingredients: water for injections; lactic acid; sorbitol; hydrochloric acid; sodium hydroxide - irinotecan hydrochloride is indicated as a component of first-line therapy for patients with metastatic carcinoma of the colon or rectum. irinotecan hydrochloride is also indicated for patients with metastatic carcinoma of the colon or rectum whose disease has recurred or progressed following initial therapy.

IRINOTECAN BAXTER irinotecan hydrochloride trihydrate 300 mg/15 mL concentrated injection vial Austrálie - angličtina - Department of Health (Therapeutic Goods Administration)

irinotecan baxter irinotecan hydrochloride trihydrate 300 mg/15 ml concentrated injection vial

baxter healthcare pty ltd - irinotecan hydrochloride trihydrate, quantity: 300 mg - injection, concentrated - excipient ingredients: lactic acid; sorbitol; hydrochloric acid; sodium hydroxide; water for injections - irinotecan hydrochloride is indicated as a component of first-line therapy for patients with metastatic carcinoma of the colon or rectum. irinotecan hydrochloride is also indicated for patients with metastatic carcinoma of the colon or rectum whose disease has recurred or progressed following initial therapy.

TRANEXAMIC ACID LUMACINA tranexamic acid 1000 mg/10 mL solution for injection ampoule Austrálie - angličtina - Department of Health (Therapeutic Goods Administration)

tranexamic acid lumacina tranexamic acid 1000 mg/10 ml solution for injection ampoule

bridgewest perth pharma pty ltd - tranexamic acid, quantity: 1000 mg - injection, solution - excipient ingredients: water for injections - intravenous administration,adults,for the reduction of peri- and post-operative blood loss and the need for blood transfusion in patients undergoing cardiac surgery or total knee arthroplasty or total hip arthroplasty.,paediatrics,for the reduction of peri- and post-operative blood loss and the need for blood transfusion in patients undergoing cardiac surgery.

Ibuprofen B. Braun 400 mg solution for infusion Irsko - angličtina - HPRA (Health Products Regulatory Authority)

ibuprofen b. braun 400 mg solution for infusion

b. braun melsungen ag - ibuprofen - solution for infusion - 400 milligram(s) - propionic acid derivatives; ibuprofen

Ibuprofen B. Braun 600 mg solution for infusion Irsko - angličtina - HPRA (Health Products Regulatory Authority)

ibuprofen b. braun 600 mg solution for infusion

b. braun melsungen ag - ibuprofen - solution for infusion - 600 milligram(s) - propionic acid derivatives; ibuprofen

B BRAUN GLUCOSE 5% injection Austrálie - angličtina - Department of Health (Therapeutic Goods Administration)

b braun glucose 5% injection

b braun australia pty ltd - glucose monohydrate, quantity: 55 g/l - injection, intravenous infusion - excipient ingredients: water for injections - for intravenous fluid therapy designed to correct deficiencies in hydration, electrolyte and energy levels. may also be used as a solvent for intravenously administered drugs where compatibility has been established.

B BRAUN GLUCOSE 5% injection Austrálie - angličtina - Department of Health (Therapeutic Goods Administration)

b braun glucose 5% injection

b braun australia pty ltd - glucose monohydrate, quantity: 55 g/l - injection, intravenous infusion - excipient ingredients: water for injections - for intravenous fluid therapy designed to correct deficiencies in hydration, electrolyte and energy levels. may also be used as a solvent for intravenously administered drugs where compatibility has been established.

IRINOTECAN ACCORD irinotecan hydrochloride trihydrate 300 mg/15 mL concentrated injection vial Austrálie - angličtina - Department of Health (Therapeutic Goods Administration)

irinotecan accord irinotecan hydrochloride trihydrate 300 mg/15 ml concentrated injection vial

accord healthcare pty ltd - irinotecan hydrochloride trihydrate, quantity: 300 mg - injection, concentrated - excipient ingredients: sodium hydroxide; lactic acid; hydrochloric acid; sorbitol; water for injections - irinotecan hydrochloride is indicated as a component of first-line therapy for patients with metastatic carcinoma of the colon or rectum. irinotecan hydrochloride is also indicated for patients with metastatic carcinoma of the colon or rectum whose disease has recurred or progressed following initial therapy.

IRINOTECAN ACCORD irinotecan hydrochloride trihydrate 500 mg/25 mL concentrated injection vial Austrálie - angličtina - Department of Health (Therapeutic Goods Administration)

irinotecan accord irinotecan hydrochloride trihydrate 500 mg/25 ml concentrated injection vial

accord healthcare pty ltd - irinotecan hydrochloride trihydrate, quantity: 500 mg - injection, concentrated - excipient ingredients: hydrochloric acid; water for injections; lactic acid; sodium hydroxide; sorbitol - irinotecan hydrochloride is indicated as a component of first-line therapy for patients with metastatic carcinoma of the colon or rectum. irinotecan hydrochloride is also indicated for patients with metastatic carcinoma of the colon or rectum whose disease has recurred or progressed following initial therapy.

Ibuprofen B. Braun 200 mg solution for infusion Irsko - angličtina - HPRA (Health Products Regulatory Authority)

ibuprofen b. braun 200 mg solution for infusion

b. braun melsungen ag - ibuprofen - solution for infusion - 200 milligram(s) - ibuprofen